Volume 2, Issue 7, Page 5 (July 2006)
9 of 29
PREVIEW
FULL TEXT
FULL-TEXT PDF (79 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
Nabilone, an orally active synthetic cannabinoid, will become available once again as a treatment for nausea and vomiting in people undergoing chemotherapy who have had an inadequate response to conventional antiemetics.
PII: S1553-3212(06)71584-9
doi:10.1016/S1553-3212(06)71584-9
© 2006 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.